Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis
Circulation · 28.01.2025 · 151 (4) · 312-321
DOI: 10.1161/circulationaha.124.069556 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Circulation, erschienen am 28.01.2025. Verfasst von Harpreet S Bhatia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, University of California, San Diego, La Jolla (H.S.B., S.T.). Hauptthemen laut MEDLINE: Lipoprotein(a), Cholesterol, LDL, Cardiovascular Diseases. Die Arbeit wurde bisher 127-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) (Lp[a]) levels are independently associated with atherosclerotic cardiovascular disease (ASCVD). However, the relationship between Lp(a) level, LDL-C level, and ASCVD risk at different thresholds is not well defined. METHODS: A participant-level meta-analysis of 27 658 participants enrolled in 6 placebo-controlled statin trials was performed to assess the association of LDL-C and Lp(a) levels with risk of fatal or nonfatal coronary heart disease events, stroke, or any coronary or carotid revascularization (ASCVD). The multivariable-adjusted association between baseline Lp(a) level and ASCVD risk was modeled continuously using generalized additive models, and the association between baseline LDL-C level and ASCVD risk by baseline Lp(a) level by Cox proportional hazards models with random effects. The joint association between Lp(a) level and statin-achieved LDL-C level with ASCVD risk was evaluated using Cox proportional hazards models. RESULTS: Compared with an Lp(a) level of 5 mg/dL, increasing levels of Lp(a) were log-linearly associated with ASCVD risk in statin- and placebo-treated patients. Among statin-treated individuals, those with Lp(a) level >50 mg/dL (≈125 nmol/L) had increased risk across all quartiles of achieved LDL-C level and absolute change in LDL-C level. Even among those with the lowest quartile of achieved LDL-C level (3.1–77.0 mg/dL), those with Lp(a) level >50 mg/dL had greater ASCVD risk (hazard ratio, 1.38 [95% CI, 1.06–1.79]) than those with Lp(a) level ≤50 mg/dL. The greatest risk was observed with both Lp(a) level >50 mg/dL and LDL-C level in the fourth quartile (hazard ratio, 1.90 [95% CI, 1.46–2.48]). CONCLUSIONS: These findings demonstrate the independent and additive nature of Lp(a) and LDL-C levels for ASCVD risk, and that LDL-C lowering does not fully offset Lp(a)-mediated risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, University of California, San Diego, La Jolla (H.S.B., S.T.).
- Novartis Pharma AG, Basel, Switzerland (S.W., A.L., K.B.).
- Department of Medical Statistics, Informatics and Health Economics at the Medical University of Innsbruck, Austria (P.W.).
- Brigham and Women's Hospital, Harvard Medical School, Boston, MA (P.M.R.).
- Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia (P.N.).
- NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia (J.S.).
ORCID-Profile: Harpreet S Bhatia, Simon Wandel, Peter Willeit, Paul M Ridker, Paul Nestel, John Simes, Andrew Tonkin, Gregory G Schwartz, Christoph Wanner, Sotirios Tsimikas
Förderung
- NHLBI NIH HHS
Zitieren
APA
Bhatia, H. S., Wandel, S., Willeit, P., Lesogor, A., Bailey, K., Ridker, P. M., Nestel, P., Simes, J., Tonkin, A., Schwartz, G. G., Colhoun, H., Wanner, C., & Tsimikas, S. (2025). Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis. Circulation, 151(4), 312-321. https://doi.org/10.1161/circulationaha.124.069556
Vancouver
Bhatia HS, Wandel S, Willeit P, Lesogor A, Bailey K, Ridker PM, et al. Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis. Circulation. 2025;151(4):312-321. doi:10.1161/circulationaha.124.069556
BibTeX
@article{Bhatia2025,
author = {Bhatia, Harpreet S and Wandel, Simon and Willeit, Peter and Lesogor, Anastasia and Bailey, Keith and Ridker, Paul M and Nestel, Paul and Simes, John and Tonkin, Andrew and Schwartz, Gregory G and Colhoun, Helen and Wanner, Christoph and Tsimikas, Sotirios},
title = {Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis},
journal = {Circulation},
year = {2025},
volume = {151},
number = {4},
pages = {312--321},
doi = {10.1161/circulationaha.124.069556}
}
EUVIMED